top of page
CELL4CURE
PERSONALIZED TOLERANCE
CELL4CURE- Personalized Tolerance
Cell4Cure AB is a Swedish biotech company pioneering immune tolerance therapies to address critical challenges such as anti-drug antibodies (ADAs), autoimmune diseases, and transplant rejection.
The company’s proprietary platform is based on ex vivo-engineered dendritic cells (DCs) designed to induce antigen-specific immune tolerance while preserving essential immune function.
Backed by $30 million in research and development investments, Cell4Cure has achieved key milestones, including European Medicines Agency (EMA) approval for clinical trials and the establishment of robust GMP manufacturing processes.
bottom of page